下肢動脈硬化閉塞癥腔內治療進展_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

 陳忠 , 楊耀國

首都醫科大學附屬北京安貞醫院血管外科，首都醫科大學血管外科學系（北京 100053）;

Corresponding?author：

陳忠, Email: chenzhong8658@vip.sina.com

Keywords：

DOI：

10.7507/1007-9424.201712104

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 陳忠, 楊耀國. 下肢動脈硬化閉塞癥腔內治療進展. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2018, 25(1): 3-9. doi: 10.7507/1007-9424.201712104 Copy

1.	中華醫學會外科學分會血管外科學組. 下肢動脈硬化閉塞癥診治指南. 中華醫學雜志, 2015, 95(24): 1883-1896.
2.	Bolia A, Miles KA, Brennan J, et al. Percutaneous transluminal angioplasty of occlusions of the femoral and popliteal arteries by subintimal dissection. Cardiovasc Intervent Radiol, 1990, 13(6): 357-363.
3.	馮志剛. 下肢動脈硬化閉塞癥患者采用內膜下血管成形術治療的臨床效果分析. 血管與腔內血管外科雜志, 2015, 11(1): 140-142.
4.	吳澤濤, 李煥祥, 馬彥壽, 等. 內膜下血管成形術治療慢性下肢長段動脈硬化閉塞癥的療效分析. 青海醫藥雜志, 2015, 45(1): 56-58.
5.	蔣米爾. 內膜下血管成形術治療下肢動脈硬化閉塞癥. 中國實用外科雜志, 2008, 28(10): 837-839.
6.	劉暴, 劉昌偉, 吳巍巍, 等. 內膜下技術治療髂動脈閉塞性疾病. 中國醫學科學院學報, 2007, 29(1): 44-46.
7.	Met R, Van Lienden KP, Koelemay MJ, et al. Subintimal angioplasty for peripheral arterial occlusive disease: a systematic review. Cardiovasc Intervent Radiol, 2008, 31(4): 687-697.
8.	李祥祥, 陸信武, 葉開創, 等. 內膜下血管成形術治療下肢動脈慢性閉塞性病變的薈萃分析. 中華醫學雜志, 2012, 92(21): 1486-1491.
9.	符偉國, 唐驍, 郭大喬. 下肢動脈閉塞性病變治療術中重返真腔的常用器械及其注意事項. 中國血管外科雜志 (電子版), 2013, 5(4): 206-208.
10.	張宏鵬, 郭偉, 劉小平, 等. 股淺動脈閉塞性病變中 Outback LTD 導管的應用分析. 中華外科雜志, 2012, 50(3): 226-229.
11.	李貝貝, 暢智慧, 馬羽佳, 等. Outback 導管輔助內膜下成形術治療下肢動脈硬化閉塞癥的文獻系統評價. 中華放射學雜志, 2015, 49(2): 143-145.
12.	Ramjas G, Thurley P, Habib S. The use of a re-entry catheter in recanalization of chronic inflow occlusions of the common iliac artery. Cardiovasc Intervent Radiol, 2008, 31(3): 650-654.
13.	Gandini R, Fabiano S, Spano S, et al. Randomized control study of the outback LTD reentry catheter versus manual reentry for the treatment of chronic total occlusions in the superficial femoral artery. Catheter Cardiovasc Interv, 2013, 82(3): 485-492.
14.	Noory E, Rastan A, Schwarzw?lder U, et al. Retrograde transpopliteal recanalization of chronic superficial femoral artery occlusion after failed re-entry during antegrade subintimal angioplasty. J Endovasc Ther, 2009, 16(5): 619-623.
15.	楊淼, 張童, 石波, 等. 遠端動脈逆行穿刺治療復雜下肢動脈閉塞性病變的初步體會. 中華放射學雜志, 2012, 46(8): 735-737.
16.	Saito S. Different strategies of retrograde approach in coronary angioplasty for chronic total occlusion. Catheter Cardiovasc Interv, 2008, 71(1): 8-19.
17.	王煒, 劉長建, 喬彤. 透視引導下遠端動脈逆行開通技術在下肢動脈慢性閉塞性疾病中的應用. 介入放射學雜志, 2015, 24(2): 110-113.
18.	谷涌泉, 郭連瑞, 郭建明, 等. 經腓動脈穿刺雙球囊技術開通股淺動脈全程閉塞導致的嚴重下肢缺血 1 例報告. 中國微創外科雜志, 2014, 20(1): 84-85.
19.	張學強, 時秀華, 李成恩, 等. 逆行突破技術在股-腘動脈閉塞癥腔內治療中的應用. 醫學影像學雜志, 2016, 26(9): 1690-1693.
20.	史偉浩, 余波, 何勍, 等. 仰臥體位下經腘動脈逆行入路治療股淺動脈慢性完全閉塞. 中國臨床醫學, 2013, 20(3): 287-288.
21.	包俊敏. 下肢動脈閉塞腔內治療策略的新思考. 中國血管外科雜志 (電子版), 2017, 9(2): 81-83.
22.	Patlola R, Hebert C, Allie D. Orbital atherectomy in treatment of peripheral arterial occlusive disease below the knee a large singl ecenter experience[J]. Am J Cardiol, 2009, 104(6): 24D-25D.
23.	Ramaiah V, Gammon R, Kiesz S, et al. Midterm outcomes from the TALON Registry: treating peripherals with SilverHawk: outcomes collection. J Endovasc Ther, 2006, 13(5): 592-602.
24.	熊江, 郭偉, 賈鑫, 等. 血管斑塊切除系統治療股淺動脈病變 (2 例報告). 軍醫進修學院學報, 2010, 31(1): 97-98.
25.	孫利坤, 王兵, 劉俊超, 等. SilverHawk 斑塊切除系統在股腘動脈硬化閉塞性疾病中的應用. 實用醫學雜志, 2017, 33(18): 3060-3063.
26.	谷涌泉, 郭連瑞, 齊立行, 等. TurboHawk 斑塊切除治療伴嚴重鈣化斑塊的下肢動脈硬化閉塞癥 2 例. 中國微創外科雜志, 2016, 16(5): 449-451.
27.	Brodmann M, Rief P, Froehlich H, et al. Neointimal hyperplasia after silverhawk atherectomy versus percutaneous transluminal angioplasty (PTA) in femoropopliteal stent reobstructions: a controlled, randomized pilot trial. Cardiovasc Intervent Radiol, 2013, 36(1): 69-74.
28.	莊俊麗, 姚野, 李敬博, 等. 經皮機械血栓旋切術在下肢血管疾病中的臨床分析. 國際外科學雜志, 2015, 42(12): 845-848.
29.	Norgren L, Hiatt WR, Dormandy JA, et al. Inter—society consernsus for the management of peripheral arterial disease(TASC II) [J]. J Vasc Surg, 2007, 45 suppl S: S5-S67.
30.	K?ksoy C, Yilmaz MF, Ba?bu? HS, et al. Pharmacomechanical thrombolysis of symptomatic acute and subacute deep vein thrombosis with a rotational thrombectomy device. J Vasc Interv Radiol, 2014, 25(12): 1895-1900.
31.	Suri R, Wholey MH, Postoak D, et al. Distal embolic protection during femoropopliteal atherectomy. Catheter Cardiovasc Interv, 2006, 67(3): 417-422.
32.	李宏偉, 羅宇東, 范海倫, 等. 經皮機械血栓清除術治療下肢動脈狹窄伴血栓形成病變的近期療效觀察. 天津醫科大學學報, 2017, 23(5): 430-433, 441.
33.	Bajorek B, Lemay KS, Magin P, et al. Implementation and evaluation of a pharmacist-led hypertension management service in primary care: outcomes and methodological challenges. Pharm Pract (Granada), 2016, 14(2): 723.
34.	Schiffrin EL, Campbell NR, Feldman RD, et al. Hypertension in Canada: Past, Present, and Future. Ann Glob Health, 2016, 82(2): 288-299.
35.	Kubaska SM, Greenberg RK. Techniques for the percutaneous treatment of acute arterial occlusion. Semin Vasc Surg, 2001, 14(2): 114-122.
36.	張雷, 陸清聲, 裴軼飛, 等. AngioJet 機械血栓抽吸技術在動脈栓塞及血栓形成中的應用體會. 中國血管外科雜志 (電子版), 2016, (03): 203-207.
37.	Minko P, Katoh M, Jaeger S, et al. Atherectomy of heavily calcified femoropopliteal stenotic lesions. J Vasc Interv Radiol, 2011, 22(7): 995-1000.
38.	Lichtenberg M, K?unicke M, Hailer B. Rotational thrombectomy as treatment option for acute and subacute occluded femoropopliteal bypasses[J]. Zeitschrifl fur Gefassmedizin, 2011, 8(4): 5-10.
39.	Dippel EJ, Makam P, Kovach R, et al. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis). JACC Cardiovasc Interv, 2015, 8(1 Pt A): 92-101.
40.	Serino F, Cao Y, Renzi C, et al. Excimer laser ablation in the treatment of total chronic obstructions in critical limb ischaemia in diabetic patients. Sustained efficacy of plaque recanalisation in mid-term results. Eur J Vasc Endovasc Surg, 2010, 39(2): 234-238.
41.	楊熙園, 沈雅平, 龍吉甫, 等. 下肢動脈硬化閉塞癥的介入治療現狀及其研究進展. 中華臨床醫師雜志 (電子版). 2016, 10:18-21.
42.	孫利坤, 王兵. 藥物涂層球囊在下肢動脈硬化閉塞性疾病中的應用進展. 實用醫學雜志, 2017, 33(14): 2415-2418.
43.	Sarode K, Spelber DA, Bhatt DL, et al. Drug delivering technology for endovascular management of infrainguinal peripheral artery disease. JACC Cardiovasc Interv, 2014, 7(8): 827-839.
44.	Speck U, Stolzenburg N, Peters D, et al. How does a drug-coated balloon work? Overview of coating techniques and their impact. J Cardiovasc Surg (Torino), 2016, 57(1): 3-11.
45.	滕樹恩, 黃錚, 洪承路, 等. 藥物涂層球囊與藥物洗脫支架治療支架內再狹窄的 Meta 分析. 實用醫學雜志, 2015, (20): 3408-3411.
46.	Tepe G, Schnorr B, Albrecht T, et al. Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial. JACC Cardiovasc Interv, 2015, 8(1 Pt A): 102-108.
47.	Tepe G, Laird J, Schneider P, et al. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation, 2015, 131(5): 495-502.
48.	Kayssi A, Al-Atassi T, Oreopoulos G, et al. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs. Cochrane Database Syst Rev, 2016, (8): CD011319.
49.	Rosenfield K, Jaff MR, White CJ, et al. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease. N Engl J Med, 2015, 373(2): 145-153.
50.	陳旭姣, 劉兆玉. 藥物涂層球囊在股腘動脈硬化性病變中的應用進展. 中國介入影像與治療學, 2017, 14(9): 576-579.
51.	Gandini R, Del Giudice C, Merolla S, et al. Treatment of chronic SFA in-stent occlusion with combined laser atherectomy and drug-eluting balloon angioplasty in patients with critical limb ischemia: a single-center, prospective, randomized study. J Endovasc Ther, 2013, 20(6): 805-814.
52.	Sixt S, Carpio Cancino OG, Treszl A, et al. Drug-coated balloon angioplasty after directional atherectomy improves outcome in restenotic femoropopliteal arteries. J Vasc Surg, 2013, 58(3): 682-686.
53.	Liistro F, Grotti S, Porto I, et al. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery). JACC Cardiovasc Interv, 2013, 6(12): 1295-1302.
54.	Ott I, Cassese S, Groha P, et al. Randomized comparison of paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation, 2017, 135(23): 2218-2226.
55.	王愛林, 徐恒, 劉軍, 等. 切割球囊擴張在股淺動脈長段閉塞治療中的作用. 中國介入心臟病學雜志, 2012, 20(3): 156-158.
56.	Hayes DJ Jr, Dougherty MJ, Calligaro KD. Management of flush superficial femoral artery occlusions with combined open femoral endarterectomy and endovascular femoral-popliteal angioplasty and stent-grafting. Ann Vasc Surg, 2011, 25(4): 559.e19-e23.
57.	王吉昌, 祿韶英. 下肢動脈慢性完全閉塞病變的開通導絲選擇及治療策略. 中華老年多器官疾病雜志, 2017, 16(10): 797-800.
58.	Ko YG, Kim JS, Choi DH, et al. Improved technical success and midterm patency with subintimal angioplasty compared to intraluminal angioplasty in long femoropopliteal occlusions. J Endovasc Ther, 2007, 14(3): 374-381.
59.	Kawasaki D, Iida O, Fukunaga M, et al. Wire Passages of 0.035-inch Looped Wire Technique for Femoropopliteal Long Total Occlusions. J Atheroscler Thromb, 2015, 22(10): 1071-1079.
60.	Tóth GG, Yamane M, Heyndrickx GR. How to select a guidewire: technical features and key characteristics. Heart, 2015, 101(8): 645-652.
61.	Baert SA, van Walsum T, Niessen WJ. Endpoint localization in guide wire tracking during endovascular interventions. Acad Radiol, 2003, 10(12): 1424-1432.
62.	顧建平, 樓文勝, 徐克. 加強下肢動脈硬化閉塞癥介入治療的研究. 介入放射學雜志, 2011, 20(10): 757-759.
63.	Aboyans V, Ricco JB, Bartelink ML, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc, available online 26 August 2017. https://doi.org/10.1016/j.ejvs.2017.07.018.
64.	莊金滿, 李選. 下肢動脈硬化閉塞癥的治療進展. 中國微創外科雜志, 2014, 14(9): 839-843.
65.	Schillinger M, Sabeti S, Dick P, et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation, 2007, 115(21): 2745-2749.
66.	Schneider JR, Verta MJ, Alonzo MJ, et al. Results with Viabahn-assisted subintimal recanalization for TASC C and TASC D superficial femoral artery occlusive disease. Vasc Endovascular Surg, 2011, 45(5): 391-397.
67.	Werner M, Paetzold A, Banning-Eichenseer U, et al. Treatment of complex atherosclerotic femoropopliteal artery disease with a self-expanding interwoven nitinol stent: midterm results from the Leipzig SUPERA 500 registry. EuroIntervention, 2014, 10(7): 861-868.

1. 中華醫學會外科學分會血管外科學組. 下肢動脈硬化閉塞癥診治指南. 中華醫學雜志, 2015, 95(24): 1883-1896.
2. Bolia A, Miles KA, Brennan J, et al. Percutaneous transluminal angioplasty of occlusions of the femoral and popliteal arteries by subintimal dissection. Cardiovasc Intervent Radiol, 1990, 13(6): 357-363.
3. 馮志剛. 下肢動脈硬化閉塞癥患者采用內膜下血管成形術治療的臨床效果分析. 血管與腔內血管外科雜志, 2015, 11(1): 140-142.
4. 吳澤濤, 李煥祥, 馬彥壽, 等. 內膜下血管成形術治療慢性下肢長段動脈硬化閉塞癥的療效分析. 青海醫藥雜志, 2015, 45(1): 56-58.
5. 蔣米爾. 內膜下血管成形術治療下肢動脈硬化閉塞癥. 中國實用外科雜志, 2008, 28(10): 837-839.
6. 劉暴, 劉昌偉, 吳巍巍, 等. 內膜下技術治療髂動脈閉塞性疾病. 中國醫學科學院學報, 2007, 29(1): 44-46.
7. Met R, Van Lienden KP, Koelemay MJ, et al. Subintimal angioplasty for peripheral arterial occlusive disease: a systematic review. Cardiovasc Intervent Radiol, 2008, 31(4): 687-697.
8. 李祥祥, 陸信武, 葉開創, 等. 內膜下血管成形術治療下肢動脈慢性閉塞性病變的薈萃分析. 中華醫學雜志, 2012, 92(21): 1486-1491.
9. 符偉國, 唐驍, 郭大喬. 下肢動脈閉塞性病變治療術中重返真腔的常用器械及其注意事項. 中國血管外科雜志 (電子版), 2013, 5(4): 206-208.
10. 張宏鵬, 郭偉, 劉小平, 等. 股淺動脈閉塞性病變中 Outback LTD 導管的應用分析. 中華外科雜志, 2012, 50(3): 226-229.
11. 李貝貝, 暢智慧, 馬羽佳, 等. Outback 導管輔助內膜下成形術治療下肢動脈硬化閉塞癥的文獻系統評價. 中華放射學雜志, 2015, 49(2): 143-145.
12. Ramjas G, Thurley P, Habib S. The use of a re-entry catheter in recanalization of chronic inflow occlusions of the common iliac artery. Cardiovasc Intervent Radiol, 2008, 31(3): 650-654.
13. Gandini R, Fabiano S, Spano S, et al. Randomized control study of the outback LTD reentry catheter versus manual reentry for the treatment of chronic total occlusions in the superficial femoral artery. Catheter Cardiovasc Interv, 2013, 82(3): 485-492.
14. Noory E, Rastan A, Schwarzw?lder U, et al. Retrograde transpopliteal recanalization of chronic superficial femoral artery occlusion after failed re-entry during antegrade subintimal angioplasty. J Endovasc Ther, 2009, 16(5): 619-623.
15. 楊淼, 張童, 石波, 等. 遠端動脈逆行穿刺治療復雜下肢動脈閉塞性病變的初步體會. 中華放射學雜志, 2012, 46(8): 735-737.
16. Saito S. Different strategies of retrograde approach in coronary angioplasty for chronic total occlusion. Catheter Cardiovasc Interv, 2008, 71(1): 8-19.
17. 王煒, 劉長建, 喬彤. 透視引導下遠端動脈逆行開通技術在下肢動脈慢性閉塞性疾病中的應用. 介入放射學雜志, 2015, 24(2): 110-113.
18. 谷涌泉, 郭連瑞, 郭建明, 等. 經腓動脈穿刺雙球囊技術開通股淺動脈全程閉塞導致的嚴重下肢缺血 1 例報告. 中國微創外科雜志, 2014, 20(1): 84-85.
19. 張學強, 時秀華, 李成恩, 等. 逆行突破技術在股-腘動脈閉塞癥腔內治療中的應用. 醫學影像學雜志, 2016, 26(9): 1690-1693.
20. 史偉浩, 余波, 何勍, 等. 仰臥體位下經腘動脈逆行入路治療股淺動脈慢性完全閉塞. 中國臨床醫學, 2013, 20(3): 287-288.
21. 包俊敏. 下肢動脈閉塞腔內治療策略的新思考. 中國血管外科雜志 (電子版), 2017, 9(2): 81-83.
22. Patlola R, Hebert C, Allie D. Orbital atherectomy in treatment of peripheral arterial occlusive disease below the knee a large singl ecenter experience[J]. Am J Cardiol, 2009, 104(6): 24D-25D.
23. Ramaiah V, Gammon R, Kiesz S, et al. Midterm outcomes from the TALON Registry: treating peripherals with SilverHawk: outcomes collection. J Endovasc Ther, 2006, 13(5): 592-602.
24. 熊江, 郭偉, 賈鑫, 等. 血管斑塊切除系統治療股淺動脈病變 (2 例報告). 軍醫進修學院學報, 2010, 31(1): 97-98.
25. 孫利坤, 王兵, 劉俊超, 等. SilverHawk 斑塊切除系統在股腘動脈硬化閉塞性疾病中的應用. 實用醫學雜志, 2017, 33(18): 3060-3063.
26. 谷涌泉, 郭連瑞, 齊立行, 等. TurboHawk 斑塊切除治療伴嚴重鈣化斑塊的下肢動脈硬化閉塞癥 2 例. 中國微創外科雜志, 2016, 16(5): 449-451.
27. Brodmann M, Rief P, Froehlich H, et al. Neointimal hyperplasia after silverhawk atherectomy versus percutaneous transluminal angioplasty (PTA) in femoropopliteal stent reobstructions: a controlled, randomized pilot trial. Cardiovasc Intervent Radiol, 2013, 36(1): 69-74.
28. 莊俊麗, 姚野, 李敬博, 等. 經皮機械血栓旋切術在下肢血管疾病中的臨床分析. 國際外科學雜志, 2015, 42(12): 845-848.
29. Norgren L, Hiatt WR, Dormandy JA, et al. Inter—society consernsus for the management of peripheral arterial disease(TASC II) [J]. J Vasc Surg, 2007, 45 suppl S: S5-S67.
30. K?ksoy C, Yilmaz MF, Ba?bu? HS, et al. Pharmacomechanical thrombolysis of symptomatic acute and subacute deep vein thrombosis with a rotational thrombectomy device. J Vasc Interv Radiol, 2014, 25(12): 1895-1900.
31. Suri R, Wholey MH, Postoak D, et al. Distal embolic protection during femoropopliteal atherectomy. Catheter Cardiovasc Interv, 2006, 67(3): 417-422.
32. 李宏偉, 羅宇東, 范海倫, 等. 經皮機械血栓清除術治療下肢動脈狹窄伴血栓形成病變的近期療效觀察. 天津醫科大學學報, 2017, 23(5): 430-433, 441.
33. Bajorek B, Lemay KS, Magin P, et al. Implementation and evaluation of a pharmacist-led hypertension management service in primary care: outcomes and methodological challenges. Pharm Pract (Granada), 2016, 14(2): 723.
34. Schiffrin EL, Campbell NR, Feldman RD, et al. Hypertension in Canada: Past, Present, and Future. Ann Glob Health, 2016, 82(2): 288-299.
35. Kubaska SM, Greenberg RK. Techniques for the percutaneous treatment of acute arterial occlusion. Semin Vasc Surg, 2001, 14(2): 114-122.
36. 張雷, 陸清聲, 裴軼飛, 等. AngioJet 機械血栓抽吸技術在動脈栓塞及血栓形成中的應用體會. 中國血管外科雜志 (電子版), 2016, (03): 203-207.
37. Minko P, Katoh M, Jaeger S, et al. Atherectomy of heavily calcified femoropopliteal stenotic lesions. J Vasc Interv Radiol, 2011, 22(7): 995-1000.
38. Lichtenberg M, K?unicke M, Hailer B. Rotational thrombectomy as treatment option for acute and subacute occluded femoropopliteal bypasses[J]. Zeitschrifl fur Gefassmedizin, 2011, 8(4): 5-10.
39. Dippel EJ, Makam P, Kovach R, et al. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis). JACC Cardiovasc Interv, 2015, 8(1 Pt A): 92-101.
40. Serino F, Cao Y, Renzi C, et al. Excimer laser ablation in the treatment of total chronic obstructions in critical limb ischaemia in diabetic patients. Sustained efficacy of plaque recanalisation in mid-term results. Eur J Vasc Endovasc Surg, 2010, 39(2): 234-238.
41. 楊熙園, 沈雅平, 龍吉甫, 等. 下肢動脈硬化閉塞癥的介入治療現狀及其研究進展. 中華臨床醫師雜志 (電子版). 2016, 10:18-21.
42. 孫利坤, 王兵. 藥物涂層球囊在下肢動脈硬化閉塞性疾病中的應用進展. 實用醫學雜志, 2017, 33(14): 2415-2418.
43. Sarode K, Spelber DA, Bhatt DL, et al. Drug delivering technology for endovascular management of infrainguinal peripheral artery disease. JACC Cardiovasc Interv, 2014, 7(8): 827-839.
44. Speck U, Stolzenburg N, Peters D, et al. How does a drug-coated balloon work? Overview of coating techniques and their impact. J Cardiovasc Surg (Torino), 2016, 57(1): 3-11.
45. 滕樹恩, 黃錚, 洪承路, 等. 藥物涂層球囊與藥物洗脫支架治療支架內再狹窄的 Meta 分析. 實用醫學雜志, 2015, (20): 3408-3411.
46. Tepe G, Schnorr B, Albrecht T, et al. Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial. JACC Cardiovasc Interv, 2015, 8(1 Pt A): 102-108.
47. Tepe G, Laird J, Schneider P, et al. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation, 2015, 131(5): 495-502.
48. Kayssi A, Al-Atassi T, Oreopoulos G, et al. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs. Cochrane Database Syst Rev, 2016, (8): CD011319.
49. Rosenfield K, Jaff MR, White CJ, et al. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease. N Engl J Med, 2015, 373(2): 145-153.
50. 陳旭姣, 劉兆玉. 藥物涂層球囊在股腘動脈硬化性病變中的應用進展. 中國介入影像與治療學, 2017, 14(9): 576-579.
51. Gandini R, Del Giudice C, Merolla S, et al. Treatment of chronic SFA in-stent occlusion with combined laser atherectomy and drug-eluting balloon angioplasty in patients with critical limb ischemia: a single-center, prospective, randomized study. J Endovasc Ther, 2013, 20(6): 805-814.
52. Sixt S, Carpio Cancino OG, Treszl A, et al. Drug-coated balloon angioplasty after directional atherectomy improves outcome in restenotic femoropopliteal arteries. J Vasc Surg, 2013, 58(3): 682-686.
53. Liistro F, Grotti S, Porto I, et al. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery). JACC Cardiovasc Interv, 2013, 6(12): 1295-1302.
54. Ott I, Cassese S, Groha P, et al. Randomized comparison of paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation, 2017, 135(23): 2218-2226.
55. 王愛林, 徐恒, 劉軍, 等. 切割球囊擴張在股淺動脈長段閉塞治療中的作用. 中國介入心臟病學雜志, 2012, 20(3): 156-158.
56. Hayes DJ Jr, Dougherty MJ, Calligaro KD. Management of flush superficial femoral artery occlusions with combined open femoral endarterectomy and endovascular femoral-popliteal angioplasty and stent-grafting. Ann Vasc Surg, 2011, 25(4): 559.e19-e23.
57. 王吉昌, 祿韶英. 下肢動脈慢性完全閉塞病變的開通導絲選擇及治療策略. 中華老年多器官疾病雜志, 2017, 16(10): 797-800.
58. Ko YG, Kim JS, Choi DH, et al. Improved technical success and midterm patency with subintimal angioplasty compared to intraluminal angioplasty in long femoropopliteal occlusions. J Endovasc Ther, 2007, 14(3): 374-381.
59. Kawasaki D, Iida O, Fukunaga M, et al. Wire Passages of 0.035-inch Looped Wire Technique for Femoropopliteal Long Total Occlusions. J Atheroscler Thromb, 2015, 22(10): 1071-1079.
60. Tóth GG, Yamane M, Heyndrickx GR. How to select a guidewire: technical features and key characteristics. Heart, 2015, 101(8): 645-652.
61. Baert SA, van Walsum T, Niessen WJ. Endpoint localization in guide wire tracking during endovascular interventions. Acad Radiol, 2003, 10(12): 1424-1432.
62. 顧建平, 樓文勝, 徐克. 加強下肢動脈硬化閉塞癥介入治療的研究. 介入放射學雜志, 2011, 20(10): 757-759.
63. Aboyans V, Ricco JB, Bartelink ML, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc, available online 26 August 2017. https://doi.org/10.1016/j.ejvs.2017.07.018.
64. 莊金滿, 李選. 下肢動脈硬化閉塞癥的治療進展. 中國微創外科雜志, 2014, 14(9): 839-843.
65. Schillinger M, Sabeti S, Dick P, et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation, 2007, 115(21): 2745-2749.
66. Schneider JR, Verta MJ, Alonzo MJ, et al. Results with Viabahn-assisted subintimal recanalization for TASC C and TASC D superficial femoral artery occlusive disease. Vasc Endovascular Surg, 2011, 45(5): 391-397.
67. Werner M, Paetzold A, Banning-Eichenseer U, et al. Treatment of complex atherosclerotic femoropopliteal artery disease with a self-expanding interwoven nitinol stent: midterm results from the Leipzig SUPERA 500 registry. EuroIntervention, 2014, 10(7): 861-868.

Previous Article
胸腔鏡縱隔手術中超聲刀的規范及強化應用
Next Article
原發性肝癌診療規范（2017 年版）解讀

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

下肢動脈硬化閉塞癥腔內治療進展

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content